Subsidy Tracker Parent Company Summary
Parent Company Name:
Bristol-Myers Squibb
Ownership Structure:
publicly traded (ticker symbol BMY)
Headquartered in:
New York
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
|---|---|---|
| State/Local | $104,856,638 | 72 |
| Federal (grants and allocated tax credits) | $32,275,480 | 10 |
| TOTAL | $137,132,118 | 82 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $0 | 0 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $0 | 0 |
| TOTAL | $0 | 0 |
Time Period for State and Local Awards:
Earliest year of data: 1997. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2009.
Time Period for Federal Awards:
FY2000 to the present
Notes:
The dollar total above adjusts for the fact that there is an overlap between the amount in the Megadeal entry and that of one or more of the other entries. Dollar totals do not include awards for which no subsidy value is disclosed.
Links:
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
|---|---|---|
| Massachusetts | $67,000,000 | 1 |
| Washington | $10,751,199 | 26 |
| New Jersey | $10,713,146 | 4 |
| New York | $8,256,425 | 32 |
| Florida | $6,279,200 | 2 |
| All other | $1,856,668 | 7 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
Download results as 
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
| Company | Location | Subsidy Source | Year |
Subsidy Value |
Loan/Bailout Value | Type of Subsidy |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb | Massachusetts | state | 2006 | $67,000,000 |
MEGADEAL  |
|
| CELGENE CORPORATION | United States | federal | 2010 | $10,061,240 | federal grant | |
| CELGENE CORPORATION | United States | federal | 2012 | $7,489,743 | federal grant | |
| Celgene Corporation | New Jersey | state | 2004 | $6,086,250 | grant | |
| ZYMOGENETICS, INC. | Washington | state | 2017 | $5,971,568 | tax credit/rebate | |
| Bristol-Myers Squibb Company | New Jersey | state | 1997 | $4,200,000 | grant | |
| CELGENE CORPORATION | United States | federal | 2011 | $3,687,247 | federal grant | |
| Bristol-Myers Squibb Co. | Florida | state | 2014 | $3,500,000 | grant | |
| CELGENE CORPORATION | United States | federal | 2009 | $3,170,533 | federal grant | |
| Bristol-Myers Squibb Co. | Florida | state | 2014 | $2,779,200 | tax credit/rebate | |
| EASEL BIOTECHNOLOGIES | United States | federal | 2015 | $2,000,000 | federal grant | |
| EASEL BIOTECHNOLOGIES | United States | federal | 2018 | $2,000,000 | federal grant | |
| CELGENE CORPORATION | United States | federal | 2011 | $1,400,000 | federal grant | |
| EASEL BIOTECHNOLOGIES | United States | federal | 2018 | $1,201,621 | federal grant | |
| EASEL BIOTECHNOLOGIES | United States | federal | 2019 | $1,201,621 | federal grant | |
| Abraxis BioScience | Iowa | state | 2008 | $662,500 | enterprise zone | |
| Bristol Myers Squibb (Mr. Leon Squibb) | New York | local | 2006 | $592,901 | tax credit/rebate; property tax abatement | |
| ZYMOGENETICS INC | Washington | state | 2007 | $518,618 | tax credit/rebate | |
| American Pharmaceutical Partners, Inc. | New York | local | 2005 | $495,039 | tax credit/rebate; property tax abatement | |
| ZYMOGENETICS INC | Washington | state | 2004 | $481,822 | tax credit/rebate | |
| Bristol Myers Squibb (Mr. Leon Squibb) | New York | local | 2007 | $478,724 | tax credit/rebate; property tax abatement | |
| ZYMOGENETICS INC | Washington | state | 2008 | $474,786 | tax credit/rebate | |
| Bristol-Myers Squibb | New York | local | 2014 | $452,064 | tax credit/rebate | |
| Bristol-Myers Squibb | New York | local | 2013 | $426,654 | tax credit/rebate; property tax abatement | |
| Bristol-Myers Squibb | New York | local | 2015 | $416,585 | tax credit/rebate | |
| Bristol-Myers Squibb | New York | local | 2016 | $414,936 | tax credit/rebate | |
| Bristol-Myers Squibb | New York | local | 2010 | $414,326 | tax credit/rebate; property tax abatement | |
| Bristol-Myers Squibb | New York | local | 2017 | $412,873 | tax credit/rebate | |
| Bristol-Myers Squibb | New York | local | 2011 | $410,028 | tax credit/rebate; property tax abatement | |
| Bristol-Myers Squibb Co., Inc. | New York | Local | 2018 | $406,056 | tax credit/rebate | |
| Abraxis BioScience | Iowa | state | 2008 | $400,000 | grant/loan hybrid program | |
| Bristol-Myers Squibb | New York | local | 2012 | $393,682 | tax credit/rebate; property tax abatement | |
| ZYMOGENETICS INC | Washington | state | 2006 | $380,245 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2005 | $375,100 | tax credit/rebate | |
| Bristol-Myers Squibb | New York | local | 2009 | $361,233 | tax credit/rebate; property tax abatement | |
| Bristol-Myers Squibb | New York | local | 2008 | $358,648 | tax credit/rebate; property tax abatement | |
| Bristol Myers Squibb (Mr. Leon Squibb) | New York | local | 2004 | $355,511 | tax credit/rebate; property tax abatement | |
| ZYMOGENETICS INC | Washington | state | 2009 | $351,337 | tax credit/rebate | |
| Celgene | New Jersey | state | 2005 | $345,800 | tax credit/rebate | |
| Bristol-Myers Squibb | New York | local | 2009 | $343,915 | tax credit/rebate; property tax abatement | |
| Bristol Myers Squibb (Mr. Leon Squibb) | New York | local | 2003 | $343,428 | tax credit/rebate; property tax abatement | |
| ZYMOGENETICS INC | Washington | state | 2004 | $333,589 | tax credit/rebate | |
| Bristol Myers Squibb (Mr. Leon Squibb) | New York | local | 2005 | $327,383 | tax credit/rebate; property tax abatement | |
| ZYMOGENETICS INC | Washington | state | 2010 | $298,738 | tax credit/rebate | |
| Abraxis BioScience, Inc. | Arizona | state | 2009 | $279,390 | training reimbursement | |
| Bristol-Myers Squibb Company, Inc. | New York | state | 2002 | $275,000 | enterprise zone | |
| ZYMOGENETICS INC | Washington | state | 2005 | $181,604 | tax credit/rebate | |
| Abraxis BioScience, LLC | Iowa | state | 2010 | $158,808 | training reimbursement | |
| ZYMOGENETICS INC | Washington | state | 2011 | $143,394 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2010 | $143,394 | tax credit/rebate | |
| Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Indiana | state | 2009 | $137,500 | training reimbursement | |
| ZYMOGENETICS INC | Washington | state | 2009 | $127,860 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2008 | $120,165 | tax credit/rebate | |
| Abraxis BioScience, LLC | Iowa | state | 2009 | $116,970 | training reimbursement | |
| ZYMOGENETICS INC | Washington | state | 2006 | $113,958 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2014 | $102,925 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2015 | $102,925 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2012 | $102,839 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2013 | $102,839 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2016 | $102,839 | tax credit/rebate | |
| Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Indiana | state | 2007 | $101,500 | training reimbursement | |
| ZYMOGENETICS INC | Washington | state | 2010 | $95,385 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2007 | $88,277 | tax credit/rebate | |
| American Pharmaceutical Partners, Inc. | New York | local | 2004 | $85,934 | tax credit/rebate; property tax abatement | |
| Celgene | New Jersey | state | 2005 | $81,096 | Tax credit/rebate | |
| CELGENE CORPORATION | United States | federal | 2010 | $63,475 | federal grant | |
| American Pharmaceutical Partners, Inc. | New York | local | 2007 | $60,433 | tax credit/rebate; property tax abatement | |
| American Pharmaceutical Partners, Inc. | New York | local | 2008 | $55,672 | tax credit/rebate; property tax abatement | |
| American Pharmaceutical Partners, Inc. | New York | local | 2009 | $54,069 | tax credit/rebate; property tax abatement | |
| American Pharmaceutical Partners, Inc. | New York | local | 2010 | $50,043 | tax credit/rebate; property tax abatement | |
| American Pharmaceutical Partners, Inc. | New York | local | 2012 | $49,186 | tax credit/rebate; property tax abatement | |
| American Pharmaceutical Partners, Inc. | New York | local | 2013 | $48,688 | tax credit/rebate; property tax abatement | |
| American Pharmaceutical Partners, Inc. | New York | local | 2011 | $48,189 | tax credit/rebate; property tax abatement | |
| American Pharmaceutical Partners, Inc. | New York | local | 2006 | $42,228 | tax credit/rebate; property tax abatement | |
| American Pharmaceutical Partners, Inc. | New York | local | 2014 | $29,980 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2012 | $19,311 | tax credit/rebate | |
| American Pharmaceutical Partners, Inc. | New York | local | 2016 | $17,837 | tax credit/rebate | |
| American Pharmaceutical Partners, Inc. | New York | local | 2017 | $17,711 | tax credit/rebate | |
| American Pharmaceutical Partners, Inc. | New York | local | 2015 | $17,469 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2011 | $12,368 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2011 | $3,872 | tax credit/rebate | |
| ZYMOGENETICS INC | Washington | state | 2013 | $1,441 | tax credit/rebate | |
| American Pharmaceutical Partners, Inc. | Illinois | state | 2005 | undisclosed | tax credit/rebate | |
| Bristol Myers Squibb Co. | Massachusetts | state | 2006 | undisclosed | tax credit/rebate | |
| ABRAXIS BIOSCIENCE LLC | Illinois | local | 2012 | undisclosed | property tax abatement |
Download results as or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
